2003
DOI: 10.1016/s0304-3940(03)00119-8
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal dietary choline availability alters postnatal neurotoxic vulnerability in the adult rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
18
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 15 publications
3
18
0
Order By: Relevance
“…When histones are deacetylated they are less permissive to gene transcription and therefore preventing deacetylation can promote gene transcription. This is a provocative target for future investigations into the mechanisms of choline’s antidepressant properties, demonstrated in the present report, but also its more general neuroprotective properties, which are well-documented (Glenn et al, 2008; Guo-Ross et al, 2003; Holmes et al, 2003; Moon et al, 2010; Nag & Berger-Sweeney, 2007; Thomas et al, 2000; 2007; Wong-Goodrich et al, 2008a; 2011). …”
Section: Discussionmentioning
confidence: 56%
See 1 more Smart Citation
“…When histones are deacetylated they are less permissive to gene transcription and therefore preventing deacetylation can promote gene transcription. This is a provocative target for future investigations into the mechanisms of choline’s antidepressant properties, demonstrated in the present report, but also its more general neuroprotective properties, which are well-documented (Glenn et al, 2008; Guo-Ross et al, 2003; Holmes et al, 2003; Moon et al, 2010; Nag & Berger-Sweeney, 2007; Thomas et al, 2000; 2007; Wong-Goodrich et al, 2008a; 2011). …”
Section: Discussionmentioning
confidence: 56%
“…Fitting extraordinarily well with these behavioral results are physiological and neural findings that the basal forebrain-hippocampal cholinergic system’s function and morphology are altered by the levels of choline in utero (Albright et al, 1999; Blusztajn et al, 1998; Craciunescu et al, 2003; Pyapali et al, 1998; Williams et al, 1998; also see Loy et al, 1991). Extending this work are findings that prenatal choline supplementation is neuroprotective against a variety of neural insults (Guo-Ross et al, 2003; Holmes et al, 2001; Thomas et al, 2000; 2007; Wong-Goodrich et al, 2008a; Yang et al, 2000) and that prenatal choline deficiency may reduce the capacity for neuroplastic changes in adult brains (Glenn et al, 2007). …”
Section: Introductionmentioning
confidence: 83%
“…In addition to the beneficial cognitive effects of MCS in normal rats and mice, this early dietary intervention provides lasting neuroprotective effects and attenuates cognitive impairment in a wide variety of rodent disease models including aging [73, 82, 9799], prenatal alcohol exposure [100102], epilepsy [103105], excitotoxicity [106, 107], Rett syndrome [108111], and notably, DS [7476, 112]. …”
Section: Effects Of Mcs On Spatial Cognition Hippocampal Neurogenesimentioning
confidence: 99%
“…Early life choline supplementation in rats, either prenatally, neonatally, or post-weaning, exerts neuroprotection in a wide array of disease models, including epilepsy (Wong-Goodrich et al, 2008b; 2011), Down syndrome (Strupp et al, 2016), Rett syndrome (Nag and Berger-Sweeney et al, 2007; Nag et al, 2009), fetal alcohol syndrome (Thomas et al, 2003; 2007; Schneider and Thomas, 2016), depression (Glenn et al, 2012; McCall et al, 2015: Schulz et al, 2014), and schizophrenia (Corriveau and Glenn, 2012; Stevens et al, 2008; 2014). In addition to these disease models, early life choline supplementation also attenuates the effects of exposure to the neurotoxin, MK-801 (Guo-Ross et al, 2002; 2003). MK-801 is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist (Wong et al, 1986) that blocks the activity of the excitatory neurotransmitter, glutamate, preventing it from activating the NMDA receptor.…”
Section: Introductionmentioning
confidence: 99%
“…Because glutamate is the primary excitatory neurotransmitter in the nervous system, the disruption of its activity by MK-801 causes a variety of problems. In rats, chronic or large acute doses of MK-801 induce motor deficits (Andiné et al, 1999), anhedonia (Vardigan et al, 2010), and neuronal degeneration (Guo-Ross et al, 2002; 2003), while low acute doses induce cognitive impairment in both spatial memory (Åhlander et al, 1999) and object recognition memory (de Lima et al, 2005). These are symptoms frequently observed in psychological disorders for which pathology is associated with reduced excitatory neurotransmission, such as schizophrenia.…”
Section: Introductionmentioning
confidence: 99%